External Link - Source: New York Times
A shift last year by the federal government in how it pays for drugs to treat dialysis patients may have had an unintended and potentially dire consequence, according to new research: a significant jump in blood transfusions for patients who now may not be getting enough of the medications. The findings are seen by some experts as a stark illustration of how the government’s reimbursement policies can drive the practice of medicine.